Committed to New Antibody Drug Discovery

Publications & Posters

Poster Presentation at the 100th Annual Meeting of American Association for Cancer Research (AACR) April 2009

• Monoclonal antibody to desmoglein 3 exhibits in vivo anti-tumor efficacy
  Kawai, S., et al.
• A new therapeutic application using GRP78-specific single chain antibody fragment (scFv) fused immnunotoxin
  Kimura, N., et al.

Poster Presentation at the 102nd Annual Meeting of American Association for Cancer Research (AACR) April 2011

• A blocking antibody to HB-EGF inhibits the growth of tumor xenograft
  Kimura, N., et al.

Press Release

• September 27, 2010: FPR Opens a New Office in Yokohama Bio Industry Center. Further Expanding Its Open Innovation Type of Drug-Discovery Research.

↑ Page Top